Regenxbio (RGNX) Return on Equity (2015 - 2025)

Regenxbio's Return on Equity history runs 11 years deep, the most recent figure standing at 0.01% for Q4 2025.

• In Q4 2025, Return on Equity fell 1.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity was 0.01% for Q4 2025 at Regenxbio, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2021 to a low of 0.01% in Q4 2025.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
• The sharpest annual moves came in 2021 and 2023: Return on Equity changed 0 bps in 2021, then slipped 1 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then plunged by 100 bps to 0.0% in 2022, then tumbled by 2109223 bps to 0.01% in 2023, then fell by 4 bps to 0.01% in 2024, then plunged by 81 bps to 0.01% in 2025.
• The last three Return on Equity figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.